Maureen O'Brien

Associate Professor of Clinical Pediatrics

University of Cincinnati

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (11)

Melinda Pauly

Assistant Professor

Emory University

UNITED STATES

View details

Sumit Gupta

University of Toronto

CANADA

View details

Robin Norris

Associate Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

Jennifer McNeer

Professor

University of Utah

UNITED STATES

View details

Ernesto Diaz-Flores

University of California, San Francisco

UNITED STATES

View details

Lynn Lee

Research Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

Franco Locatelli

Full Professor of Pediatrics

Catholic University of the Sacred Heart

ITALY

View details

KRZYSZTOF KALWAK

MD, PhD, Prof.

Wroclaw Medical University

POLAND

View details

Michael Burke

Associate Professor

Medical College of Wisconsin

UNITED STATES

View details

KENICHI ISHIYAMA

Assistant professor

Kyoto University

JAPAN

View details

Jeremy Rubinstein

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maureen O'Brien

Research Interests

Explore related searches

Contact this professor

Articles (9)

The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL

CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia

Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia

Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group

Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621

Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short‐course EPOCH regimens are safe and effective

Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia

Defining the Optimal Treatment of First Relapse of Pediatric Relapsed Anaplastic Large-Cell Lymphoma: Clinical Trial Challenges for Rare Diagnoses

Collaborators (11)

Melinda Pauly

Sumit Gupta

Robin Norris

Jennifer McNeer

Ernesto Diaz-Flores

Lynn Lee

Franco Locatelli

KRZYSZTOF KALWAK

Michael Burke

KENICHI ISHIYAMA

Jeremy Rubinstein

Make your next move.